Cargando…
Quantifying beta cell function in the preclinical stages of type 1 diabetes
Clinically symptomatic type 1 diabetes (stage 3 type 1 diabetes) is preceded by a pre-symptomatic phase, characterised by progressive loss of functional beta cell mass after the onset of islet autoimmunity, with (stage 2) or without (stage 1) measurable changes in glucose profile during an OGTT. Ide...
Autores principales: | Galderisi, Alfonso, Carr, Alice L. J., Martino, Mariangela, Taylor, Peter, Senior, Peter, Dayan, Colin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627950/ https://www.ncbi.nlm.nih.gov/pubmed/37712956 http://dx.doi.org/10.1007/s00125-023-06011-5 |
Ejemplares similares
-
Beta cell function in the early stages of type 1 diabetes: still a long way ahead of us
por: Galderisi, Alfonso
Publicado: (2023) -
Obstructive sleep apnea (OSA) is associated with the impairment of beta-cell response to glucose in children and adolescents with obesity
por: Umano, Giuseppina Rosaria, et al.
Publicado: (2023) -
Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
por: Huber, Colin M., et al.
Publicado: (2017) -
Cardiac Autoimmunity as a Novel Biomarker, Mediator, and Therapeutic Target of Heart Disease in Type 1 Diabetes
por: Lipes, Myra A., et al.
Publicado: (2015) -
Sex differences in mechanical allodynia: how can it be preclinically quantified and analyzed?
por: Nicotra, Lauren, et al.
Publicado: (2014)